title: Answer to the Letter to the Editor of H. Namazi concerning "Denosumab: a potential new and innovative treatment option for aneurysmal bone cysts" by Lange T, Stehling C, Fröhlich B, Klingenhöfer M, Kunkel P, Schneppenheim R, Escherich G, Gosheger G, Hardes J, Jürgens H, Schulte TL (2013), Eur Spine J;22(6):1417-1422.
authors: Department of Orthopedics and Tumor Orthopedics, Münster University Hospital, Albert-Schweitzer-Campus 1, 48149, Münster, Germany, tobias.lange@ukmuenster.de.
authors: T
authors: T
authors: Lange
authors: T L
authors: TL
authors: Schulte
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D017824:Bone Cysts, Aneurysmal / Q000188:drug therapy*; D006801:Humans; D008297:Male; D013122:Spinal Diseases / Q000188:drug therapy*
chemical_list: D061067:Antibodies, Monoclonal, Humanized
references: Endocrinology. 2007 Jun;148(6):2635-43
references: 17395698
references: J Clin Endocrinol Metab. 2011 May;96(5):1555-9
references: 21367927
references: J Bone Miner Res. 2012 Nov;27(11):2259-63
references: 22692843
references: Eur Spine J. 2013 Jun;22(6):1417-22
references: 23455951